Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

ethypharm - morphine sulphate - solution for injection - 10 milligram(s)/millilitre - natural opium alkaloids; morphine

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - furosemide, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium hydroxide; nitrogen; sodium chloride - oedema: furosemide ? aft is indicated in adults, infants and children for the treatment of oedema associated with congestive heart failure, cirrhosis of the liver and renal disease including the nephrotic syndrome. it is particularly useful when an agent with greater diuretic potential than that of those commonly employed is desired. parenteral therapy should be reserved for patients unable to take oral medication or for patients in emergency clinical situations.,furosemide ? aft injection is also indicated as adjunctive therapy in acute pulmonary oedema and cerebral oedema where intense and rapid onset of diuresis is desired. if gastrointestinal absorption is impaired or oral medication is not practical for any reason, furosemide ? aft is indicated by the intravenous route. parenteral use should be replaced with oral furosemide as soon as practical.

Νέα Ζηλανδία - Αγγλικά - Medsafe (Medicines Safety Authority)

juno pharmaceuticals nz limited - morphine hydrochloride trihydrate 10 mg/ml equivalent to morphine base 7.58 mg/ml - solution for injection - 50 mg/5ml - active: morphine hydrochloride trihydrate 10 mg/ml equivalent to morphine base 7.58 mg/ml excipient: hydrochloric acid water for injection - morphine hydrochloride is indicated for: - the relief of moderate to severe pain not responsive to non-opioid analgesics - symptomatic relief of severe and intractable pains of various categories, in terminal cancer patients - use as a pre-operative medication and as an analgesic adjunct in general anaesthesia

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

paddock laboratories, llc - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 100 mg in 5 ml - morphine sulfate oral solution is indicated for the management of acute and chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. morphine sulfate oral solution 100 mg per 5 ml (20 mg/ml) is indicated for the relief of acute and chronic pain in opioid-tolerant patients. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.2) ], reserve morphine sulfate oral solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: morphine sulfate oral solution is contraindicated in patients with: risk summary prolonged use of opioid analgesics during pregnancy can cause neonatal opioid withdrawal syndrome [see warnings and precautions (5.5) ]. there are no available data with morphine sulfate oral solution in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. published s

Μάλτα - Αγγλικά - Medicines Authority

macarthys laboratories limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - morphine sulfate - solution for injection - morphine sulfate 30 mg/ml - analgesics

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals (ireland) ltd - morphine sulfate - solution for injection - 1 mg/5ml - natural opium alkaloids; morphine

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

martindale pharmaceuticals ltd - morphine sulfate - solution for injection - 30 milligram(s)/millilitre - natural opium alkaloids; morphine

Μάλτα - Αγγλικά - Medicines Authority

sopharma plc - morphine hydrochloride 20 mg/ml - solution for injection

Ιρλανδία - Αγγλικά - HPRA (Health Products Regulatory Authority)

zoetis ireland limited - doxapram hydrochloride - solution for injection - 20 mg/ml - doxapram - bovine, canine, equine - food, feline, ovine - respiratory tract preparations

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

vistapharm, inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 10 mg in 5 ml - morphine sulfate oral solution is indicated for the management of acute and chronic pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. morphine sulfate oral solution 100 mg per 5 ml (20 mg/ml) is indicated for the relief of acute and chronic pain in opioid-tolerant patients. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.2) ], reserve morphine sulfate oral solution for use in patients for whom alternative treatment options [e.g., non-opioid analgesics or opioid combination products]: - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia morphine sulfate oral solution is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.4) ]. - acute or severe bronchial asthma in an unmonitored setting or in the absence of resus